Alert # 1:
Due to Merck’s continued hepatitis B supply shortage which will continue in 2020, GSK is experiencing increased demand for ENGERIX-B. In order to manage our inventory, GSK will begin to limit the amount of ENGERIX-B that customers can order on GSKDirect. Customers will see GSKDirect order limits placed on both the pediatric and adult formulations of ENGERIX-B as we manage GSK’s supply of hepatitis B vaccines during this Merck supply shortage.
Alert # 2:
Due to unprecedented levels of demand for SHINGRIX, providers should anticipate ordering limits, backorders and shipping delays for SHINGRIX. GSK is currently working to make more doses available in the near term for the US market in order to meet the demand for this vaccine.
Alert # 3:
Attention GSKDirect Customers: For Important Information regarding updated design for GSK Vaccines, please click here.
